Evaluating VEGFR2 as a Target for Anti-Tumour Therapy in Canine Melanoma
Article Details
-
Date Published
March 18, 2026
Hindriks E, Bergmann W, Ruiz AM, Zandvliet M, Sijts A, Broere F. Evaluating VEGFR2 as a Target for Anti-Tumour Therapy in Canine Melanoma. Vet Comp Oncol. 2026 Mar. 24:95–104. doi:10.1111/vco.70029. PMID: 41319225